-
1
-
-
33846506812
-
Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer
-
Anderson M.J., Shafer-Weaver K., Greenberg N.M., Hurwitz A.A. Tolerization of tumor-specific T cells despite efficient initial priming in a primary murine model of prostate cancer. J. Immunol. 2007, 178:1268-1276.
-
(2007)
J. Immunol.
, vol.178
, pp. 1268-1276
-
-
Anderson, M.J.1
Shafer-Weaver, K.2
Greenberg, N.M.3
Hurwitz, A.A.4
-
3
-
-
51349149926
-
Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice
-
Bai A., Higham E., Eisen H.N., Wittrup K.D., Chen J. Rapid tolerization of virus-activated tumor-specific CD8+ T cells in prostate tumors of TRAMP mice. Proc. Natl. Acad. Sci. USA 2008, 105:13003-13008.
-
(2008)
Proc. Natl. Acad. Sci. USA
, vol.105
, pp. 13003-13008
-
-
Bai, A.1
Higham, E.2
Eisen, H.N.3
Wittrup, K.D.4
Chen, J.5
-
4
-
-
77549083441
-
Transforming growth factor beta (TGF-beta) and inflammation in cancer
-
Bierie B., Moses H.L. Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 2010, 21:49-59.
-
(2010)
Cytokine Growth Factor Rev.
, vol.21
, pp. 49-59
-
-
Bierie, B.1
Moses, H.L.2
-
5
-
-
34547689270
-
Do autochthonous tumors interfere with effector T cell responses?
-
Blankenstein T. Do autochthonous tumors interfere with effector T cell responses?. Semin. Cancer Biol. 2007, 17:267-274.
-
(2007)
Semin. Cancer Biol.
, vol.17
, pp. 267-274
-
-
Blankenstein, T.1
-
6
-
-
0033842854
-
CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene
-
Boesen M., Svane I.M., Engel A.M., Rygaard J., Thomsen A.R., Werdelin O. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene. Clin. Exp. Immunol. 2000, 121:210-215.
-
(2000)
Clin. Exp. Immunol.
, vol.121
, pp. 210-215
-
-
Boesen, M.1
Svane, I.M.2
Engel, A.M.3
Rygaard, J.4
Thomsen, A.R.5
Werdelin, O.6
-
7
-
-
33646179699
-
Human T cell responses against melanoma
-
Boon T., Coulie P.G., Van den Eynde B.J., van der Bruggen P. Human T cell responses against melanoma. Annu. Rev. Immunol. 2006, 24:175-208.
-
(2006)
Annu. Rev. Immunol.
, vol.24
, pp. 175-208
-
-
Boon, T.1
Coulie, P.G.2
Van den Eynde, B.J.3
van der Bruggen, P.4
-
8
-
-
4644237613
-
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
-
Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med. 2004, 10:942-949.
-
(2004)
Nat. Med.
, vol.10
, pp. 942-949
-
-
Curiel, T.J.1
Coukos, G.2
Zou, L.3
Alvarez, X.4
Cheng, P.5
Mottram, P.6
Evdemon-Hogan, M.7
Conejo-Garcia, J.R.8
Zhang, L.9
Burow, M.10
-
10
-
-
0036852241
-
Cancer immunoediting: From immunosurveillance to tumor escape
-
Dunn G.P., Bruce A.T., Ikeda H., Old L.J., Schreiber R.D. Cancer immunoediting: From immunosurveillance to tumor escape. Nat. Immunol. 2002, 3:991-998.
-
(2002)
Nat. Immunol.
, vol.3
, pp. 991-998
-
-
Dunn, G.P.1
Bruce, A.T.2
Ikeda, H.3
Old, L.J.4
Schreiber, R.D.5
-
11
-
-
77954951446
-
The polarization of immune cells in the tumour environment by TGFbeta
-
Flavell R.A., Sanjabi S., Wrzesinski S.H., Licona-Limón P. The polarization of immune cells in the tumour environment by TGFbeta. Nat. Rev. Immunol. 2010, 10:554-567.
-
(2010)
Nat. Rev. Immunol.
, vol.10
, pp. 554-567
-
-
Flavell, R.A.1
Sanjabi, S.2
Wrzesinski, S.H.3
Licona-Limón, P.4
-
12
-
-
77957723967
-
Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients
-
Fourcade J., Sun Z., Benallaoua M., Guillaume P., Luescher I.F., Sander C., Kirkwood J.M., Kuchroo V., Zarour H.M. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 2010, 207:2175-2186.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 2175-2186
-
-
Fourcade, J.1
Sun, Z.2
Benallaoua, M.3
Guillaume, P.4
Luescher, I.F.5
Sander, C.6
Kirkwood, J.M.7
Kuchroo, V.8
Zarour, H.M.9
-
13
-
-
5644248080
-
RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo
-
Friese M.A., Wischhusen J., Wick W., Weiler M., Eisele G., Steinle A., Weller M. RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res. 2004, 64:7596-7603.
-
(2004)
Cancer Res.
, vol.64
, pp. 7596-7603
-
-
Friese, M.A.1
Wischhusen, J.2
Wick, W.3
Weiler, M.4
Eisele, G.5
Steinle, A.6
Weller, M.7
-
14
-
-
33646356996
-
Adoptive immunotherapy for cancer: Building on success
-
Gattinoni L., Powell D.J., Rosenberg S.A., Restifo N.P. Adoptive immunotherapy for cancer: Building on success. Nat. Rev. Immunol. 2006, 6:383-393.
-
(2006)
Nat. Rev. Immunol.
, vol.6
, pp. 383-393
-
-
Gattinoni, L.1
Powell, D.J.2
Rosenberg, S.A.3
Restifo, N.P.4
-
15
-
-
0035914134
-
Regulation of cutaneous malignancy by gammadelta T cells
-
Girardi M., Oppenheim D.E., Steele C.R., Lewis J.M., Glusac E., Filler R., Hobby P., Sutton B., Tigelaar R.E., Hayday A.C. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001, 294:605-609.
-
(2001)
Science
, vol.294
, pp. 605-609
-
-
Girardi, M.1
Oppenheim, D.E.2
Steele, C.R.3
Lewis, J.M.4
Glusac, E.5
Filler, R.6
Hobby, P.7
Sutton, B.8
Tigelaar, R.E.9
Hayday, A.C.10
-
16
-
-
0034131557
-
Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease
-
Gorelik L., Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
-
(2000)
Immunity
, vol.12
, pp. 171-181
-
-
Gorelik, L.1
Flavell, R.A.2
-
17
-
-
0034770605
-
Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells
-
Gorelik L., Flavell R.A. Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells. Nat. Med. 2001, 7:1118-1122.
-
(2001)
Nat. Med.
, vol.7
, pp. 1118-1122
-
-
Gorelik, L.1
Flavell, R.A.2
-
18
-
-
0028911462
-
Prostate cancer in a transgenic mouse
-
Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., Rosen J.M. Prostate cancer in a transgenic mouse. Proc. Natl. Acad. Sci. USA 1995, 92:3439-3443.
-
(1995)
Proc. Natl. Acad. Sci. USA
, vol.92
, pp. 3439-3443
-
-
Greenberg, N.M.1
DeMayo, F.2
Finegold, M.J.3
Medina, D.4
Tilley, W.D.5
Aspinall, J.O.6
Cunha, G.R.7
Donjacour, A.A.8
Matusik, R.J.9
Rosen, J.M.10
-
19
-
-
41549163195
-
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
-
Guerra N., Tan Y.X., Joncker N.T., Choy A., Gallardo F., Xiong N., Knoblaugh S., Cado D., Greenberg N.M., Raulet D.H. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008, 28:571-580.
-
(2008)
Immunity
, vol.28
, pp. 571-580
-
-
Guerra, N.1
Tan, Y.X.2
Joncker, N.T.3
Choy, A.4
Gallardo, F.5
Xiong, N.6
Knoblaugh, S.7
Cado, D.8
Greenberg, N.M.9
Raulet, D.H.10
-
20
-
-
79952771167
-
Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation
-
Gutcher I., Donkor M.K., Ma Q., Rudensky A.Y., Flavell R.A., Li M.O. Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 2011, 34:396-408.
-
(2011)
Immunity
, vol.34
, pp. 396-408
-
-
Gutcher, I.1
Donkor, M.K.2
Ma, Q.3
Rudensky, A.Y.4
Flavell, R.A.5
Li, M.O.6
-
21
-
-
44449149448
-
The TRAMP mouse as a model for prostate cancer
-
Unit 20 25
-
Hurwitz A.A., Foster B.A., Allison J.P., Greenberg N.M., Kwon E.D. The TRAMP mouse as a model for prostate cancer. Curr. Protoc. Immunol. 2001, Chapter 20. Unit 20 25.
-
(2001)
Curr. Protoc. Immunol.
, vol.20
-
-
Hurwitz, A.A.1
Foster, B.A.2
Allison, J.P.3
Greenberg, N.M.4
Kwon, E.D.5
-
22
-
-
0037379315
-
Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine
-
Kao J.Y., Gong Y., Chen C.M., Zheng Q.D., Chen J.J. Tumor-derived TGF-beta reduces the efficacy of dendritic cell/tumor fusion vaccine. J. Immunol. 2003, 170:3806-3811.
-
(2003)
J. Immunol.
, vol.170
, pp. 3806-3811
-
-
Kao, J.Y.1
Gong, Y.2
Chen, C.M.3
Zheng, Q.D.4
Chen, J.J.5
-
23
-
-
42649125225
-
PD-1 and its ligands in tolerance and immunity
-
Keir M.E., Butte M.J., Freeman G.J., Sharpe A.H. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 2008, 26:677-704.
-
(2008)
Annu. Rev. Immunol.
, vol.26
, pp. 677-704
-
-
Keir, M.E.1
Butte, M.J.2
Freeman, G.J.3
Sharpe, A.H.4
-
24
-
-
1642577616
-
Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution
-
Klein G., Klein E. Immune surveillance against virus-induced tumors and nonrejectability of spontaneous tumors: Contrasting consequences of host versus tumor evolution. Proc. Natl. Acad. Sci. USA 1977, 74:2121-2125.
-
(1977)
Proc. Natl. Acad. Sci. USA
, vol.74
, pp. 2121-2125
-
-
Klein, G.1
Klein, E.2
-
25
-
-
36849010167
-
Adaptive immunity maintains occult cancer in an equilibrium state
-
Koebel C.M., Vermi W., Swann J.B., Zerafa N., Rodig S.J., Old L.J., Smyth M.J., Schreiber R.D. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007, 450:903-907.
-
(2007)
Nature
, vol.450
, pp. 903-907
-
-
Koebel, C.M.1
Vermi, W.2
Swann, J.B.3
Zerafa, N.4
Rodig, S.J.5
Old, L.J.6
Smyth, M.J.7
Schreiber, R.D.8
-
26
-
-
35649024275
-
Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins
-
Lacy-Hulbert A., Smith A.M., Tissire H., Barry M., Crowley D., Bronson R.T., Roes J.T., Savill J.S., Hynes R.O. Ulcerative colitis and autoimmunity induced by loss of myeloid alphav integrins. Proc. Natl. Acad. Sci. USA 2007, 104:15823-15828.
-
(2007)
Proc. Natl. Acad. Sci. USA
, vol.104
, pp. 15823-15828
-
-
Lacy-Hulbert, A.1
Smith, A.M.2
Tissire, H.3
Barry, M.4
Crowley, D.5
Bronson, R.T.6
Roes, J.T.7
Savill, J.S.8
Hynes, R.O.9
-
27
-
-
0033056073
-
Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients
-
Lee P.P., Yee C., Savage P.A., Fong L., Brockstedt D., Weber J.S., Johnson D., Swetter S., Thompson J., Greenberg P.D., et al. Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 1999, 5:677-685.
-
(1999)
Nat. Med.
, vol.5
, pp. 677-685
-
-
Lee, P.P.1
Yee, C.2
Savage, P.A.3
Fong, L.4
Brockstedt, D.5
Weber, J.S.6
Johnson, D.7
Swetter, S.8
Thompson, J.9
Greenberg, P.D.10
-
28
-
-
48449086316
-
TGF-beta: A master of all T cell trades
-
Li M.O., Flavell R.A. TGF-beta: A master of all T cell trades. Cell 2008, 134:392-404.
-
(2008)
Cell
, vol.134
, pp. 392-404
-
-
Li, M.O.1
Flavell, R.A.2
-
29
-
-
33748448717
-
Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms
-
Li M.O., Sanjabi S., Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471.
-
(2006)
Immunity
, vol.25
, pp. 455-471
-
-
Li, M.O.1
Sanjabi, S.2
Flavell, R.A.3
-
30
-
-
34248592104
-
T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation
-
Li M.O., Wan Y.Y., Flavell R.A. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 2007, 26:579-591.
-
(2007)
Immunity
, vol.26
, pp. 579-591
-
-
Li, M.O.1
Wan, Y.Y.2
Flavell, R.A.3
-
31
-
-
33847337912
-
Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: Role of tumor-derived TGF-beta
-
Liu V.C., Wong L.Y., Jang T., Shah A.H., Park I., Yang X., Zhang Q., Lonning S., Teicher B.A., Lee C. Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: Role of tumor-derived TGF-beta. J. Immunol. 2007, 178:2883-2892.
-
(2007)
J. Immunol.
, vol.178
, pp. 2883-2892
-
-
Liu, V.C.1
Wong, L.Y.2
Jang, T.3
Shah, A.H.4
Park, I.5
Yang, X.6
Zhang, Q.7
Lonning, S.8
Teicher, B.A.9
Lee, C.10
-
32
-
-
33748465396
-
Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor
-
Marie J.C., Liggitt D., Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006, 25:441-454.
-
(2006)
Immunity
, vol.25
, pp. 441-454
-
-
Marie, J.C.1
Liggitt, D.2
Rudensky, A.Y.3
-
33
-
-
47549090432
-
TGFbeta in cancer
-
Massagué J. TGFbeta in cancer. Cell 2008, 134:215-230.
-
(2008)
Cell
, vol.134
, pp. 215-230
-
-
Massagué, J.1
-
34
-
-
45549085803
-
An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments
-
Nam J.S., Terabe M., Mamura M., Kang M.J., Chae H., Stuelten C., Kohn E., Tang B., Sabzevari H., Anver M.R., et al. An anti-transforming growth factor beta antibody suppresses metastasis via cooperative effects on multiple cell compartments. Cancer Res. 2008, 68:3835-3843.
-
(2008)
Cancer Res.
, vol.68
, pp. 3835-3843
-
-
Nam, J.S.1
Terabe, M.2
Mamura, M.3
Kang, M.J.4
Chae, H.5
Stuelten, C.6
Kohn, E.7
Tang, B.8
Sabzevari, H.9
Anver, M.R.10
-
35
-
-
77953267301
-
Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development
-
Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
-
(2010)
Immunity
, vol.32
, pp. 642-653
-
-
Ouyang, W.1
Beckett, O.2
Ma, Q.3
Li, M.O.4
-
36
-
-
0042470540
-
Does the immune system see tumors as foreign or self?
-
Pardoll D. Does the immune system see tumors as foreign or self?. Annu. Rev. Immunol. 2003, 21:807-839.
-
(2003)
Annu. Rev. Immunol.
, vol.21
, pp. 807-839
-
-
Pardoll, D.1
-
37
-
-
70349742484
-
Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model
-
Pu H., Collazo J., Jones E., Gayheart D., Sakamoto S., Vogt A., Mitchell B., Kyprianou N. Dysfunctional transforming growth factor-beta receptor II accelerates prostate tumorigenesis in the TRAMP mouse model. Cancer Res. 2009, 69:7366-7374.
-
(2009)
Cancer Res.
, vol.69
, pp. 7366-7374
-
-
Pu, H.1
Collazo, J.2
Jones, E.3
Gayheart, D.4
Sakamoto, S.5
Vogt, A.6
Mitchell, B.7
Kyprianou, N.8
-
38
-
-
77949522803
-
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
-
Quezada S.A., Simpson T.R., Peggs K.S., Merghoub T., Vider J., Fan X., Blasberg R., Yagita H., Muranski P., Antony P.A., et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J. Exp. Med. 2010, 207:637-650.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 637-650
-
-
Quezada, S.A.1
Simpson, T.R.2
Peggs, K.S.3
Merghoub, T.4
Vider, J.5
Fan, X.6
Blasberg, R.7
Yagita, H.8
Muranski, P.9
Antony, P.A.10
-
40
-
-
38149035080
-
Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes
-
Savage P.A., Vosseller K., Kang C., Larimore K., Riedel E., Wojnoonski K., Jungbluth A.A., Allison J.P. Recognition of a ubiquitous self antigen by prostate cancer-infiltrating CD8+ T lymphocytes. Science 2008, 319:215-220.
-
(2008)
Science
, vol.319
, pp. 215-220
-
-
Savage, P.A.1
Vosseller, K.2
Kang, C.3
Larimore, K.4
Riedel, E.5
Wojnoonski, K.6
Jungbluth, A.A.7
Allison, J.P.8
-
42
-
-
0035953308
-
IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity
-
Shankaran V., Ikeda H., Bruce A.T., White J.M., Swanson P.E., Old L.J., Schreiber R.D. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410:1107-1111.
-
(2001)
Nature
, vol.410
, pp. 1107-1111
-
-
Shankaran, V.1
Ikeda, H.2
Bruce, A.T.3
White, J.M.4
Swanson, P.E.5
Old, L.J.6
Schreiber, R.D.7
-
43
-
-
0034695880
-
Differential tumor surveillance by natural killer (NK) and NKT cells
-
Smyth M.J., Thia K.Y., Street S.E., Cretney E., Trapani J.A., Taniguchi M., Kawano T., Pelikan S.B., Crowe N.Y., Godfrey D.I. Differential tumor surveillance by natural killer (NK) and NKT cells. J. Exp. Med. 2000, 191:661-668.
-
(2000)
J. Exp. Med.
, vol.191
, pp. 661-668
-
-
Smyth, M.J.1
Thia, K.Y.2
Street, S.E.3
Cretney, E.4
Trapani, J.A.5
Taniguchi, M.6
Kawano, T.7
Pelikan, S.B.8
Crowe, N.Y.9
Godfrey, D.I.10
-
44
-
-
0034605122
-
Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
-
Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J. Exp. Med. 2000, 192:755-760.
-
(2000)
J. Exp. Med.
, vol.192
, pp. 755-760
-
-
Smyth, M.J.1
Thia, K.Y.2
Street, S.E.3
MacGregor, D.4
Godfrey, D.I.5
Trapani, J.A.6
-
45
-
-
0036645530
-
Suppression of lymphoma and epithelial malignancies effected by interferon gamma
-
Street S.E., Trapani J.A., MacGregor D., Smyth M.J. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J. Exp. Med. 2002, 196:129-134.
-
(2002)
J. Exp. Med.
, vol.196
, pp. 129-134
-
-
Street, S.E.1
Trapani, J.A.2
MacGregor, D.3
Smyth, M.J.4
-
46
-
-
0029787726
-
Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice
-
Svane I.M., Engel A.M., Nielsen M.B., Ljunggren H.G., Rygaard J., Werdelin O. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice. Eur. J. Immunol. 1996, 26:1844-1850.
-
(1996)
Eur. J. Immunol.
, vol.26
, pp. 1844-1850
-
-
Svane, I.M.1
Engel, A.M.2
Nielsen, M.B.3
Ljunggren, H.G.4
Rygaard, J.5
Werdelin, O.6
-
47
-
-
34248193253
-
Immune surveillance of tumors
-
Swann J.B., Smyth M.J. Immune surveillance of tumors. J. Clin. Invest. 2007, 117:1137-1146.
-
(2007)
J. Clin. Invest.
, vol.117
, pp. 1137-1146
-
-
Swann, J.B.1
Smyth, M.J.2
-
48
-
-
27644457376
-
TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
-
Thomas D.A., Massagué J. TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance. Cancer Cell 2005, 8:369-380.
-
(2005)
Cancer Cell
, vol.8
, pp. 369-380
-
-
Thomas, D.A.1
Massagué, J.2
-
49
-
-
0025055406
-
A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance
-
Torre-Amione G., Beauchamp R.D., Koeppen H., Park B.H., Schreiber H., Moses H.L., Rowley D.A. A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. USA 1990, 87:1486-1490.
-
(1990)
Proc. Natl. Acad. Sci. USA
, vol.87
, pp. 1486-1490
-
-
Torre-Amione, G.1
Beauchamp, R.D.2
Koeppen, H.3
Park, B.H.4
Schreiber, H.5
Moses, H.L.6
Rowley, D.A.7
-
50
-
-
34548208943
-
Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice
-
Travis M.A., Reizis B., Melton A.C., Masteller E., Tang Q., Proctor J.M., Wang Y., Bernstein X., Huang X., Reichardt L.F., et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007, 449:361-365.
-
(2007)
Nature
, vol.449
, pp. 361-365
-
-
Travis, M.A.1
Reizis, B.2
Melton, A.C.3
Masteller, E.4
Tang, Q.5
Proctor, J.M.6
Wang, Y.7
Bernstein, X.8
Huang, X.9
Reichardt, L.F.10
-
51
-
-
4644342928
-
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells
-
Turk M.J., Guevara-Patiño J.A., Rizzuto G.A., Engelhorn M.E., Sakaguchi S., Houghton A.N. Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med. 2004, 200:771-782.
-
(2004)
J. Exp. Med.
, vol.200
, pp. 771-782
-
-
Turk, M.J.1
Guevara-Patiño, J.A.2
Rizzuto, G.A.3
Engelhorn, M.E.4
Sakaguchi, S.5
Houghton, A.N.6
-
52
-
-
0029616324
-
Perforin dependence of natural killer cell-mediated tumor control in vivo
-
van den Broek M.F., Kägi D., Zinkernagel R.M., Hengartner H. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 1995, 25:3514-3516.
-
(1995)
Eur. J. Immunol.
, vol.25
, pp. 3514-3516
-
-
van den Broek, M.F.1
Kägi, D.2
Zinkernagel, R.M.3
Hengartner, H.4
-
53
-
-
24344436369
-
Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance
-
Willimsky G., Blankenstein T. Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 2005, 437:141-146.
-
(2005)
Nature
, vol.437
, pp. 141-146
-
-
Willimsky, G.1
Blankenstein, T.2
-
54
-
-
46949109577
-
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
-
Willimsky G., Czéh M., Loddenkemper C., Gellermann J., Schmidt K., Wust P., Stein H., Blankenstein T. Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J. Exp. Med. 2008, 205:1687-1700.
-
(2008)
J. Exp. Med.
, vol.205
, pp. 1687-1700
-
-
Willimsky, G.1
Czéh, M.2
Loddenkemper, C.3
Gellermann, J.4
Schmidt, K.5
Wust, P.6
Stein, H.7
Blankenstein, T.8
-
55
-
-
77949530108
-
Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma
-
Xie Y., Akpinarli A., Maris C., Hipkiss E.L., Lane M., Kwon E.K., Muranski P., Restifo N.P., Antony P.A. Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J. Exp. Med. 2010, 207:651-667.
-
(2010)
J. Exp. Med.
, vol.207
, pp. 651-667
-
-
Xie, Y.1
Akpinarli, A.2
Maris, C.3
Hipkiss, E.L.4
Lane, M.5
Kwon, E.K.6
Muranski, P.7
Restifo, N.P.8
Antony, P.A.9
-
56
-
-
31644432589
-
Regulatory T cells in immune surveillance and treatment of cancer
-
Yamaguchi T., Sakaguchi S. Regulatory T cells in immune surveillance and treatment of cancer. Semin. Cancer Biol. 2006, 16:115-123.
-
(2006)
Semin. Cancer Biol.
, vol.16
, pp. 115-123
-
-
Yamaguchi, T.1
Sakaguchi, S.2
-
57
-
-
20144387943
-
Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: Eradication of autologous mouse prostate cancer
-
Zhang Q., Yang X., Pins M., Javonovic B., Kuzel T., Kim S.J., Parijs L.V., Greenberg N.M., Liu V., Guo Y., Lee C. Adoptive transfer of tumor-reactive transforming growth factor-beta-insensitive CD8+ T cells: Eradication of autologous mouse prostate cancer. Cancer Res. 2005, 65:1761-1769.
-
(2005)
Cancer Res.
, vol.65
, pp. 1761-1769
-
-
Zhang, Q.1
Yang, X.2
Pins, M.3
Javonovic, B.4
Kuzel, T.5
Kim, S.J.6
Parijs, L.V.7
Greenberg, N.M.8
Liu, V.9
Guo, Y.10
Lee, C.11
|